drugset / Trial / NCT05917587
Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes
RandomizedParallel-groupTriple-blindBasic science
Summary
The purpose of this investigation is to examine the mechanisms mediating vascular dysfunction in women who have had gestational diabetes and how metformin may be a valuable treatment tool to improve microvascular function in these women before the onset of disease.
Timeline
- Start
- 2024-09-11
- Primary completion
- 2027-12-31
- Completion
- 2028-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metformin | Small molecule | 850 mg | — |